Published in Hum Reprod on December 17, 2004
Advances in the treatment of fragile X syndrome. Pediatrics (2009) 3.10
Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A (2008) 2.91
A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry (2009) 1.98
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med (2012) 1.85
Advances in understanding the molecular basis of FXTAS. Hum Mol Genet (2010) 1.83
Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry (2010) 1.79
FMR1: a gene with three faces. Biochim Biophys Acta (2009) 1.77
CGG repeat in the FMR1 gene: size matters. Clin Genet (2011) 1.68
FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet (2005) 1.67
Testing for fragile X gene mutations throughout the life span. JAMA (2008) 1.65
An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn (2010) 1.58
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging (2008) 1.57
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism (2010) 1.57
Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet (2006) 1.53
Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet (2012) 1.49
Histone H2AFX Links Meiotic Chromosome Asynapsis to Prophase I Oocyte Loss in Mammals. PLoS Genet (2015) 1.49
Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol (2011) 1.39
NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet (2007) 1.37
The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet (2009) 1.37
A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn (2009) 1.33
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet (2010) 1.31
Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology (2008) 1.31
Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics (2010) 1.31
Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med (2009) 1.27
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol (2012) 1.24
Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol (2011) 1.21
Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet (2008) 1.20
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. Future Neurol (2009) 1.17
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet (2010) 1.14
An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1). Mol Cytogenet (2008) 1.12
Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments. Brain Cogn (2011) 1.12
Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet (2009) 1.11
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet (2011) 1.08
New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics (2011) 1.06
Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A (2012) 1.04
Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. RNA (2007) 1.04
Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet (2010) 1.04
Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet (2012) 1.03
The FMR1 gene, infertility, and reproductive decision-making: a review. Front Genet (2014) 1.02
Daily health symptoms of mothers of adolescents and adults with fragile x syndrome and mothers of adolescents and adults with autism spectrum disorder. J Autism Dev Disord (2012) 0.99
Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol (2008) 0.99
The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS One (2011) 0.97
The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet (2011) 0.96
FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord (2011) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice. Hum Mol Genet (2012) 0.95
Broad clinical involvement in a family affected by the fragile X premutation. J Dev Behav Pediatr (2009) 0.94
FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J Mol Diagn (2011) 0.94
Associated features in females with an FMR1 premutation. J Neurodev Disord (2014) 0.94
Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod (2011) 0.91
Fragile X spectrum disorders. Intractable Rare Dis Res (2014) 0.91
Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. Am J Med Genet B Neuropsychiatr Genet (2014) 0.91
CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet (2014) 0.90
Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin Genet (2014) 0.90
Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet (2012) 0.89
Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med (2011) 0.88
Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI). J Neurodev Disord (2014) 0.88
Cis-acting DNA sequence at a replication origin promotes repeat expansion to fragile X full mutation. J Cell Biol (2014) 0.86
EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet (2014) 0.86
Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2014) 0.86
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Front Genet (2014) 0.86
Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol (2012) 0.84
Premature ovarian failure: a critical condition in the reproductive potential with various genetic causes. Int J Fertil Steril (2014) 0.83
Young adult male carriers of the fragile X premutation exhibit genetically modulated impairments in visuospatial tasks controlled for psychomotor speed. J Neurodev Disord (2012) 0.83
Mutation analysis of NANOS3 in 80 Chinese and 88 Caucasian women with premature ovarian failure. Fertil Steril (2007) 0.83
Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age. Menopause (2014) 0.83
How the FMR1 gene became relevant to female fertility and reproductive medicine. Front Genet (2014) 0.83
Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency. Eur J Hum Genet (2011) 0.83
The impact of FMR1 gene mutations on human reproduction and development: a systematic review. J Assist Reprod Genet (2016) 0.82
Genomic studies in fragile X premutation carriers. J Neurodev Disord (2014) 0.82
Biomarkers in the Study of Families of Individuals with Developmental Disabilities. Int Rev Res Ment Retard (2009) 0.82
Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet (2014) 0.82
Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report. BMC Med Genet (2007) 0.82
Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther (2014) 0.81
Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology (2011) 0.81
Molecular cytogenetic analysis of Xq critical regions in premature ovarian failure. Mol Cytogenet (2013) 0.80
Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). Reprod Health (2014) 0.80
Neurological and endocrine phenotypes of fragile X carrier women. Clin Genet (2015) 0.80
Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers. PLoS One (2014) 0.80
FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behav Brain Funct (2011) 0.80
Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding. Front Hum Neurosci (2012) 0.80
Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women. Int J Fertil Steril (2015) 0.79
Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening. Genet Test Mol Biomarkers (2011) 0.79
Ovarian aging and premature ovarian failure. J Turk Ger Gynecol Assoc (2014) 0.79
Evidence of an age-related correlation of ovarian reserve and FMR1 repeat number among women with "normal" CGG repeat status. J Assist Reprod Genet (2015) 0.79
Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency. Front Genet (2014) 0.78
Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable Rare Dis Res (2015) 0.78
Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study. J Autism Dev Disord (2013) 0.78
Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology (2011) 0.78
Reduced neurotrophin receptor tropomyosin-related kinase A expression in human granulosa cells: a novel marker of diminishing ovarian reserve. Fertil Steril (2011) 0.78
Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses. PLoS One (2014) 0.77
Postpartum Depression in Women with the FMR1 Premutation. Curr Psychiatry Rev (2015) 0.77
X-chromosome terminal deletion in a female with premature ovarian failure: Haploinsufficiency of X-linked genes as a possible explanation. Mol Cytogenet (2010) 0.77
Analysis of LHX8 mutation in premature ovarian failure. Fertil Steril (2007) 0.77
Developmental profiles of infants with an FMR1 premutation. J Neurodev Disord (2016) 0.77
Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. Clin Neuropsychol (2016) 0.77
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol (2016) 0.77
Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus. Hum Reprod (2012) 0.76
Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause. Hum Reprod (2016) 0.76
Report of the Committee on the Genetic Constitution of Chromosomes 1 and 2. Cytogenet Cell Genet (1985) 7.70
National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study. Health Serv Res (1999) 5.14
FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med (2001) 3.84
Newborn intensive care and neonatal mortality in low-birth-weight infants: a population study. N Engl J Med (1982) 3.51
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet (1984) 3.17
Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet (1996) 3.13
Population-based study of congenital heart defects in Down syndrome. Am J Med Genet (1998) 2.74
The heart in hypertension. N Engl J Med (1992) 2.53
A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J Biol Chem (1988) 2.33
Genetic analysis of glutamate transport and glutamate decarboxylase in Escherichia coli. J Bacteriol (1967) 2.31
Report of the committee on the genetic constitution of chromosome 1. Cytogenet Cell Genet (1989) 2.18
Genetic analysis of the glutamate permease in Escherichia coli K-12. J Bacteriol (1969) 2.05
The phylogenetic history of immunodeficiency viruses. Nature (1988) 1.89
Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology (2000) 1.76
Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet (1998) 1.75
Effects of competition, predation, and dispersal on species richness at local and regional scales. Am Nat (2001) 1.70
Segregation analysis of balanced pericentric inversions in pedigree data. Clin Genet (1986) 1.65
Effect of meiotic recombination on the production of aneuploid gametes in humans. Cytogenet Genome Res (2005) 1.61
Control of DNA synthesis in Bacillus subtilis by phage phi e. Virology (1971) 1.60
Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet (2000) 1.57
Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21. Hum Mol Genet (1997) 1.57
The metabolic pathway of glutamate in Escherichia coli K-12. Biochim Biophys Acta (1969) 1.55
Breast-feeding among women exposed to polybrominated biphenyls in Michigan. Environ Health Perspect (2001) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites. II. Female reproductive disorders. Reprod Toxicol (1997) 1.50
Report of the committee on linkage and gene order. Cytogenet Cell Genet (1990) 1.48
XY chromosome nondisjunction in man is associated with diminished recombination in the pseudoautosomal region. Am J Hum Genet (1991) 1.47
Mapping of DNAase I sensitive regions on mitotic chromosomes. Cell (1984) 1.45
Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod (2007) 1.42
Use of tetrazolium salts for electron transport studies in meningopneumonitis. I. Reduced nicotinamide adenine dinucleotide system. J Bacteriol (1965) 1.42
Protection of mice against vaccinia virus by bacterial infection and sustained stimulation with specific bacterial antigens. Infect Immun (1973) 1.42
Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet (1999) 1.41
A method for examining personnel in dental care delivery: application in 14 practices. Public Health Rep (1976) 1.39
Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis (1995) 1.38
Guidelines for human linkage maps: an international system for human linkage maps (ISLM, 1990). Genomics (1991) 1.37
Human genes containing polymorphic trinucleotide repeats. Nat Genet (1992) 1.37
Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome? Am J Med (1994) 1.36
Determinants of polybrominated biphenyl serum decay among women in the Michigan PBB cohort. Environ Health Perspect (2000) 1.36
Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet (2010) 1.33
Simple methods for assessing haplotype-environment interactions in case-only and case-control studies. Genet Epidemiol (2007) 1.29
Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am J Hum Genet (1996) 1.28
Non-disjunction in human sperm: evidence for an effect of increasing paternal age. Hum Mol Genet (1995) 1.26
A comparison of unmet needs for dental and medical care among persons with HIV infection receiving care in the United States. J Public Health Dent (2001) 1.26
Guidelines for human linkage maps. An International System for Human Linkage Maps (ISLM, 1990). Ann Hum Genet (1991) 1.25
Isolation by a replica-plating technique of Chinese hamster temperature-sensitive cell cycle mutants. J Cell Physiol (1982) 1.25
Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome. Am J Hum Genet (2000) 1.25
Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet (2009) 1.25
Sodium-dependent glutamate transport in membrane vesicles of Escherichia coli K-12. FEBS Lett (1975) 1.25
Postpartum depression: a critical review. Psychol Bull (1984) 1.24
Tobacco withdrawal in women and menstrual cycle phase. J Consult Clin Psychol (2000) 1.24
Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet (1996) 1.23
Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. Hum Mol Genet (1998) 1.18
Fanconi anemia: evidence for linkage heterogeneity on chromosome 20q. Genomics (1991) 1.18
Regulation of mouse satellite DNA replication time. EMBO J (1988) 1.16
A revised map of chromosome 1. Ann Hum Genet (1984) 1.16
Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J Infect Dis (1996) 1.15
Paternal nondisjunction in trisomy 21: excess of male patients. Hum Mol Genet (1993) 1.15
Human-mouse cell hybrid with human multiple Y chromosomes. Nature (1976) 1.13
Distribution of lod scores under uncertain mode of inheritance. Am J Hum Genet (1993) 1.12
Mutations in alpha- and beta-tubulin affect spindle formation in Chinese hamster ovary cells. J Cell Biol (1983) 1.12
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet (1992) 1.12
The genetic analysis of mammalian cell-cycle mutants. Annu Rev Genet (1985) 1.12
Examination of factors associated with instability of the FMR1 CGG repeat. Am J Hum Genet (1998) 1.11
A record review model for assessing dental practices. CDA J (1979) 1.10
A randomised controlled trial of postural interventions for prevention of musculoskeletal symptoms among computer users. Occup Environ Med (2005) 1.09
Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). Menopause (1999) 1.09
Measurement variability in upper extremity posture among VDT users. Appl Ergon (1997) 1.09
The issue of confounding in epidemiological studies of ambient air pollution and pregnancy outcomes. J Epidemiol Community Health (2009) 1.08
Use of dental care by HIV-infected medical patients. J Dent Res (2000) 1.08
Mapping of the aspartase gene in Escherichia coli K-12. Isr J Med Sci (1969) 1.08
Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod (2008) 1.07
DNA hypomethylation causes an increase in DNase-I sensitivity and an advance in the time of replication of the entire inactive X chromosome. Chromosoma (1985) 1.05
Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation (1981) 1.04
Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Ann Neurol (1992) 1.04
Genetic and physiological analysis of glutamate decarboxylase in Escherichia coli K-12. J Bacteriol (1969) 1.04
Measurements of coronary velocity and reactive hyperemia in the coronary circulation of humans. Circ Res (1981) 1.03
In situ nick-translation distinguishes between active and inactive X chromosomes. Nature (1983) 1.03
Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control study. Genet Med (2001) 1.03
Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet (2008) 1.03
Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect? Am J Hum Genet (2000) 1.03
Neurotoxic effects of solvent exposure on sewage treatment workers. Arch Environ Health (1988) 1.02
Risk factors for nondisjunction of trisomy 21. Cytogenet Genome Res (2005) 1.02
Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population. Am J Hum Genet (2000) 1.02
Fragile X CGG repeat structures among African-Americans: identification of a novel factor responsible for repeat instability. Hum Mol Genet (2000) 1.02
Estimating meiotic exchange patterns from recombination data: an application to humans. Genetics (1997) 1.01
Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the today study. Diabetes Care (2011) 1.01
Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet (1995) 1.01
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C. Mol Psychiatry (2011) 1.01
Factors associated with the use of screening mammography in a primary care setting. J Community Health (1994) 1.00
Normal variation at the myotonic dystrophy locus in global human populations. Am J Hum Genet (1995) 1.00
Carbon dioxide pneumoamnios causes acidosis in fetal lamb. Fetal Diagn Ther (1994) 0.98
Factors involved in the initial mutation of the fragile X CGG repeat as determined by sperm small pool PCR. Hum Mol Genet (2000) 0.98
Acute bilateral blindness in meningeal carcinomatosis. Eye (Lond) (2004) 0.97
Estimating treatment and treatment times for special and nonspecial patients in hospital ambulatory dental clinics. J Dent Educ (1986) 0.96
Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Qual Life Res (2002) 0.96